Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

Clinical trial NCT00068770 · TERMINATED

Trial details

NCT number

NCT00068770

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2003-10-01

Primary completion

2005-05-01

Enrollment

35

View on ClinicalTrials.gov